• 1
    Chuang DT, Shih VE. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill; 2001: 19712006.
  • 2
    Marshall L, Di George A. Maple Syrup urine disease in the old order Mennonites. Am J Hum Gen. 1981; 33: 139A.
  • 3
    Simon E, Flaschker N, Schadewaldt P, Langenbeck U, Wendel U. Variant maple syrup urine disease (MSUD) - the entire spectrum. J Inherit Metab Dis. 2006; 29: 716724.
  • 4
    Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002; 109: 9991008.
  • 5
    Naughten ER, Jenkins J, Francis DE, Leonard JV. Outcome of maple syrup urine disease. Arch Dis Child. 1982; 57: 918921.
  • 6
    Gouider-Khouja N, Kraoua I, Benrhouma H, Fraj N, Rouissi A. Movement disorders in neuro-metabolic diseases. Eur J Paediatr Neurol. 2010; 14: 304307.
  • 7
    le Roux C, Murphy E, Hallam P, Lilburn M, Orlowska D, Lee P. Neuropsychometric outcome predictors for adults with maple syrup urine disease. J Inherit Metab Dis. 2006; 29: 201202.
  • 8
    Morris MD, Lewis BD, Doolan PD, Harper HA. Clinical and biochemical observations on an apparently nonfatal variant of branched-chain ketoaciduria (maple syrup urine disease). Pediatrics. 1961; 28: 918923.
  • 9
    Temudo T, Martins E, Poças F, Cruz R, Vilarinho L. Maple syrup disease presenting as paroxysmal dystonia. Ann Neurol. 2004; 56: 749750.
  • 10
    Steinlin M, Blaser S, Boltshauser E. Cerebellar involvement in metabolic disorders: a pattern-recognition approach. Neuroradiology. 1998; 40: 347354.
  • 11
    Kiil R, Rokkones T. Late manifesting variant of branched-chain ketoaciduria (maple syrup urine disease). Acta Paediatr. 1964; 53: 356364.
  • 12
    Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol. 1998; 56: 507540.
  • 13
    Zinnanti WJ, Lazovic J, Griffin K, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009; 132: 903918.
  • 14
    Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain. 2003; 126: 12791292.
  • 15
    Trender-Gerhard I, Sweeney MG, Schwingenschuh P, et al. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry. 2009; 80: 839845.
  • 16
    Cif L, Biolsi B, Gavarini S, et al. Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease. Mov Disord. 2007; 22: 21262129.
  • 17
    Taira T, Kobayashi T, Hori T. Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus. Case report. J Neurosurg. 2003; 98: 414416.